Macrophagic myofasciitis and subcutaneous pseudolymphoma caused by aluminium adjuvants (Q97549735)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32678281%20AND%20SRC:MED&resulttype=core&format=json

20 July 2020

title

Macrophagic myofasciitis and subcutaneous pseudolymphoma caused by aluminium adjuvants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32678281%20AND%20SRC:MED&resulttype=core&format=json

20 July 2020

main subject

macrophagic myofasciitis

1 reference

1 reference

Hyunhee Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32678281%20AND%20SRC:MED&resulttype=core&format=json

20 July 2020

Ka Young Lim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32678281%20AND%20SRC:MED&resulttype=core&format=json

20 July 2020

Jeongwan Kang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32678281%20AND%20SRC:MED&resulttype=core&format=json

20 July 2020

Jin Woo Park

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32678281%20AND%20SRC:MED&resulttype=core&format=json

20 July 2020

Sung-Hye Park

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32678281%20AND%20SRC:MED&resulttype=core&format=json

20 July 2020

publication date

16 July 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32678281%20AND%20SRC:MED&resulttype=core&format=json

20 July 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32678281%20AND%20SRC:MED&resulttype=core&format=json

20 July 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32678281%20AND%20SRC:MED&resulttype=core&format=json

20 July 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32678281%20AND%20SRC:MED&resulttype=core&format=json

20 July 2020

page(s)

11834

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32678281%20AND%20SRC:MED&resulttype=core&format=json

Advances in aluminum hydroxide-based adjuvant research and its mechanism

20 July 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Aluminum in vaccines: Does it create a safety problem?

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Biopersistence and brain translocation of aluminum adjuvants of vaccines

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Childhood macrophagic myofasciitis-consanguinity and clinicopathological features

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Childhood macrophagic myofasciitis: A series from the Indian subcontinent.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Française contre les Myopathies (AFM).

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Macrophagic Myofasciitis in Childhood: A Controversial Entity

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Macrophagic myofasciitis in children is a localized reaction to vaccination

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Vaccine safety controversies and the future of vaccination programs

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Aluminium overload after 5 years in skin biopsy following post-vaccination with subcutaneous pseudolymphoma

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Polyglandular autoimmunity with macrophagic myofasciitis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Fluorescent nanodiamonds as a relevant tag for the assessment of alum adjuvant particle biodisposition

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Macrophagic myofasciitis: a report of second case from UK

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Central nervous system disease in patients with macrophagic myofasciitis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Neuropsychological Correlates of Brain Perfusion SPECT in Patients with Macrophagic Myofasciitis.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF).

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Cerebral 18F-FDG PET in macrophagic myofasciitis: An individual SVM-based approach.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Human adjuvant-related syndrome or autoimmune/inflammatory syndrome induced by adjuvants. Where have we come from? Where are we going? A proposal for new diagnostic criteria.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Macrophagic myofasciitis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Macrophagic myofasciitis: an infantile Italian case

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Atypical presentation of macrophagic myofasciitis 10 years post vaccination

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

Th2-M2 immunity in lesions of muscular sarcoidosis and macrophagic myofasciitis.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021

AlOH3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic background.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-68849-8

7 January 2021